NCT05310877

Brief Summary

Heart failure (HF) represents a significant public health concern. Medication non-adherence represents a modifiable contributor to costly hospital readmissions in older adults with HF. Educational interventions improve, but do not eliminate, non-adherence. Values affirmation interventions which invite individuals to reflect on core values may encourage better engagement in health behaviors by increasing the personal relevance of targeted behaviors. Similar interventions have promoted weight loss, increased adherence and physical activity, and more frequent fruit and vegetable consumption in a variety of contexts and populations. This study seeks to test a recently developed values-affirmation intervention targeting medication adherence in older adults with HF enrolled in cardiac rehabilitation (CR). The purpose of this feasibility study is to test methodology to aid development of a subsequent randomized controlled pilot trial to examine preliminary efficacy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable heart-failure

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 23, 2022

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

March 22, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 5, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2022

Completed
11 months until next milestone

Results Posted

Study results publicly available

June 22, 2023

Completed
Last Updated

June 22, 2023

Status Verified

September 1, 2022

Enrollment Period

6 months

First QC Date

March 22, 2022

Results QC Date

May 2, 2023

Last Update Submit

May 30, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Feasibility of Recruitment Procedures

    Proportion of eligible participants who enroll in the study

    Baseline

  • Feasibility of Intervention Procedures

    Proportion of enrolled participants who complete the study

    Week 4

  • Acceptability Assessed Via Qualitative Exit Interview- Number of Participants Who Completed Interview

    Qualitative exit interview to assess patient reported satisfaction with intervention content, intervention delivery, and study procedures

    Week 4

Secondary Outcomes (1)

  • Self-reported Medication Adherence

    Baseline, 4 weeks

Study Arms (1)

Values-affirmation

EXPERIMENTAL
Behavioral: Values-Affirmation

Interventions

Participants will engage in a brief values-affirmation exercise to target personal motivation and openness to medication adherence. The interventionist will then review tailored medication education and individual skills training recommendations. Following the intervention session, participants will receive electronic pill box(es) that are labeled with the participants' most important core value(s) and will be asked to use these pill box(es) to take their HF medications for 4 weeks.

Values-affirmation

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Heart failure
  • Enrolled in cardiac rehabilitation
  • Read and understand English
  • At risk for medication non-adherence based on self-report screening or number of prescribed medications

You may not qualify if:

  • Current participation in another medication-monitoring clinical or research protocol
  • New York Heart Association class IV heart failure
  • Diagnosis of Alzheimer's, dementia, or severe cognitive impairment indicated on screening
  • Current suicidality or psychosis
  • Terminal illness with an expected lifespan of less than 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Miriam Hospital

Providence, Rhode Island, 02906, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Results Point of Contact

Title
Emily Gathright, PhD
Organization
The Miriam Hospital

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2022

First Posted

April 5, 2022

Study Start

February 23, 2022

Primary Completion

August 11, 2022

Study Completion

August 11, 2022

Last Updated

June 22, 2023

Results First Posted

June 22, 2023

Record last verified: 2022-09

Locations